With its 5th edition conducted on June 15-16, 2018, in Budapest, the Pneumo Update Europe has already become a traditional manifestation, with a multitude of echoes in the pneumological world. The evidence was the increase in number of participants that reached 750 in 2018, and the generous offer on topics such as chronic obstructive pul-monary disease (COPD), pneumonia, pulmonary endoscopy, bronchial asthma, etc. However, this meeting on the update of disease information has started with a review of the posters that have increased in number from year to year. The secret of the success of this manifestation is generated by the participation of the same opinion leaders, well-known scientific personalities who have an important syn-thesis capacity in filtering this medical information in the field during one year.
Thus, on the chapter on tuberculosis and infections, prof. Cristoph Lang (Germany) reviewed the progress made in the rapid diagnosis of this contagious disease and the new thera-pies for multidrug-resistant cases. In the oncology field, Johan Vansteenkiste (Belgium) approached the new biological treat-ments and their way of integration into the complete diagnosis of lung cancer. The subject of allergy was covered by professor Stephan Durham (UK), and asthma news was presented by professor Ronald Buhl (Germany), who mainly addressed the phenotypes and endoplasmic reticulum stress in asthma, as well as how to integrate the new strategies for controlling severe asthma. COPD hasn’t been forgotten either. Here, pro-fessor David Halpin (UK) has marked the way in which the new bronchodilator associations can be assimilated and has brought pro and con arguments for the triple therapy. In the somnology chapter, professor Walter McNicholas (Ireland) reviewed the therapeutic advances in sleep apnea syndrome and the question marks left by studies that had analyzed the development of sleep-related comorbidities. The interstitial diseases were under the magnifying glass of Luca Richeldi (Italy), who detailed the results of various forms of illness, as well as the new antifibrotic therapies with the possible com-binations that could be achieved. The novelty of this manifestation was rep-resented by the pulmonary imagistic topic – what does the scientific world say about it (prof. Ulrich Kauczor, from Germany) and the update on alpha-1 antitrypsin deficiency.
Day two was as rich in offers. In pulmonary vascu-lar disease, professor Marc Humbert (France) approached both the progress of the rare forms of vasculitis and the frequent ones, followed by prof. Felix Herth (Germany), who exposed new studies related to the solitary nodule, cryobiopsy and interventions in COPD. A special part was dedicated to acute respiratory failure and intensive care, where prof. Paolo Pelosi (Italy) talked about the reclassification of acute respiratory distress syndrome, non-invasive ventilation in this condition and routine nebu-lisation. Pleural diseases were reviewed by prof. Julius Janssen (Netherlands), who showed new approaches to pleu-ral infections and mesothelioma. In the last part of the meet-ing it was highlighted, under the pneumonia chapter, the interference of steroid pneumonia, the effects of cardiovas-cular pneumonia in the community and fan-induced infec-tions, by Mark Woodhead (UK), and the transplant registers with their lessons by prof. Gilbert Massard (France).
In conclusion, prof. Ronald Buhl, the soul and the initia-tor of this event, awarded the prizes for the best posters. The Romanian presence was important – over 30 col-leagues, which drew the attention of the organizers. One of the Romanian posters, about the relationship between the doctor and the patient with COPD, was among the award receivers on this occasion.
Thus, having reached the 5th edition, this manifestation remains an important point in the annual calendar of inter-national pneumology, and the quality of the speakers, as well as their extremely didactic and synthetic way of approaching the important topics from the practitioner’s life may shorten the access of the latter to the novelties of the year of diagnostic and therapy strategies.